Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Domino55on May 27, 2021 1:00pm
109 Views
Post# 33276295

RE:RE:SP off 30%+ since Seto became CEO

RE:RE:SP off 30%+ since Seto became CEO

AP- that is a worthy question in my opinion but the ticker EDT seems to operate in a separate universe with little relationship to the scientific and developmental progress itself.


the Kellum hiring seemed to validate that science with a near doubling of the share price over the course of a few weeks. The Seto appointment then de coupled the share price again and we are where we are. Why did his appointment start the low volume sell off that continued right through some significant milestones like Canadian approval and the 20 year rights extension.

No one can explain the phenomena 

<< Previous
Bullboard Posts
Next >>